User login
Purpose: In oncology, wait times for new consults create stress and adverse outcomes; wait times for acute problems in established patients lead to ER visits with increased cost, inconvenience, and sometimes admissions, which could have been avoided. In addition, VA wait times are under public scrutiny.
Background: The CVAMC, partnering with UC, previously had 12 fellows in the H/O program, 3 of which were funded by the VA. Fellows have a VA continuity clinic staffed by 4 faculty, and rotate on the inpatient consult service. We applied for an additional fellow position through the VACAA GME program, which was granted, funded, and started in 2016; the way in which we have utilized this position forms the basis for this report.
Methods: We created a mandatory monthly outpatient VA Core rotation, which became the Urgent Fellow because of two of its primary mandates: see all urgent non-lifethreatening problems in established patients, and offer all new malignancy referrals a same or next day appointment. We encouraged referral earlier in the diagnostic evaluation. We tracked time from initial CPRS referral to visit, and % actually seen within 2 weekdays, excluding patients who declined to be seen soon. We also counted all ER visits for established patients with lung and prostate cancer.
Results: From March 2016 to Jan 2018, median referral to visit days decreased from 5 to 1, and the percent seen in < 2 days rose from 12% to 85.7%. Additional and updated numbers will be presented.
The ER visits by our patients with lung and prostate cancer fell from 230 in 2014-2015 to 114 in 2016-2017.
The Urgent Fellow rotation was the highest rated rotation at the VA / UC as judged by the fellows.
Conclusions: The creation of the Heme Onc Urgent fellow VA rotation has reaped dividends in dramatically reducing both ER visits and wait times for new malignancy referrals. Fellows have the opportunity to do the diagnostic and staging work ups, discuss treatment options, then treat and follow the patient for the remainder of their fellowship. It has improved care, reduced costs, and provided an irreplaceable experience for the fellows.
Purpose: In oncology, wait times for new consults create stress and adverse outcomes; wait times for acute problems in established patients lead to ER visits with increased cost, inconvenience, and sometimes admissions, which could have been avoided. In addition, VA wait times are under public scrutiny.
Background: The CVAMC, partnering with UC, previously had 12 fellows in the H/O program, 3 of which were funded by the VA. Fellows have a VA continuity clinic staffed by 4 faculty, and rotate on the inpatient consult service. We applied for an additional fellow position through the VACAA GME program, which was granted, funded, and started in 2016; the way in which we have utilized this position forms the basis for this report.
Methods: We created a mandatory monthly outpatient VA Core rotation, which became the Urgent Fellow because of two of its primary mandates: see all urgent non-lifethreatening problems in established patients, and offer all new malignancy referrals a same or next day appointment. We encouraged referral earlier in the diagnostic evaluation. We tracked time from initial CPRS referral to visit, and % actually seen within 2 weekdays, excluding patients who declined to be seen soon. We also counted all ER visits for established patients with lung and prostate cancer.
Results: From March 2016 to Jan 2018, median referral to visit days decreased from 5 to 1, and the percent seen in < 2 days rose from 12% to 85.7%. Additional and updated numbers will be presented.
The ER visits by our patients with lung and prostate cancer fell from 230 in 2014-2015 to 114 in 2016-2017.
The Urgent Fellow rotation was the highest rated rotation at the VA / UC as judged by the fellows.
Conclusions: The creation of the Heme Onc Urgent fellow VA rotation has reaped dividends in dramatically reducing both ER visits and wait times for new malignancy referrals. Fellows have the opportunity to do the diagnostic and staging work ups, discuss treatment options, then treat and follow the patient for the remainder of their fellowship. It has improved care, reduced costs, and provided an irreplaceable experience for the fellows.
Purpose: In oncology, wait times for new consults create stress and adverse outcomes; wait times for acute problems in established patients lead to ER visits with increased cost, inconvenience, and sometimes admissions, which could have been avoided. In addition, VA wait times are under public scrutiny.
Background: The CVAMC, partnering with UC, previously had 12 fellows in the H/O program, 3 of which were funded by the VA. Fellows have a VA continuity clinic staffed by 4 faculty, and rotate on the inpatient consult service. We applied for an additional fellow position through the VACAA GME program, which was granted, funded, and started in 2016; the way in which we have utilized this position forms the basis for this report.
Methods: We created a mandatory monthly outpatient VA Core rotation, which became the Urgent Fellow because of two of its primary mandates: see all urgent non-lifethreatening problems in established patients, and offer all new malignancy referrals a same or next day appointment. We encouraged referral earlier in the diagnostic evaluation. We tracked time from initial CPRS referral to visit, and % actually seen within 2 weekdays, excluding patients who declined to be seen soon. We also counted all ER visits for established patients with lung and prostate cancer.
Results: From March 2016 to Jan 2018, median referral to visit days decreased from 5 to 1, and the percent seen in < 2 days rose from 12% to 85.7%. Additional and updated numbers will be presented.
The ER visits by our patients with lung and prostate cancer fell from 230 in 2014-2015 to 114 in 2016-2017.
The Urgent Fellow rotation was the highest rated rotation at the VA / UC as judged by the fellows.
Conclusions: The creation of the Heme Onc Urgent fellow VA rotation has reaped dividends in dramatically reducing both ER visits and wait times for new malignancy referrals. Fellows have the opportunity to do the diagnostic and staging work ups, discuss treatment options, then treat and follow the patient for the remainder of their fellowship. It has improved care, reduced costs, and provided an irreplaceable experience for the fellows.